Streptococcus pneumoniae type 22f capsular polysaccharide antigen Completed Phase 3 Trials for Pneumococcal Diseases Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT03760146Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults